Skip to main content

Closed

BLTE: Belite Bio, Inc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-12.7%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio33.71×

Belite Bio, Inc

BLTENASDAQ Capital Market·USD·Closed

Belite Bio, Inc

BLTENASDAQ·USD·Closed

$158.61

−0.82%

$158.61

−$1.31 (0.82%)

52W Range

70thpctl

Volume

0.78×avg

Mkt Cap

6.36BUSD

P/E

-62.2TTM

Div Yield

–ann

52W Range

70thpctl

Volume

0.78×avg

Market Cap

6.36BUSD

P/E Ratio

-62.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings